{
  "id": "5a7877c0faa1ab7d2e00000c",
  "type": "factoid",
  "question": "What is the first line treatment for sarcoidosis?",
  "ideal_answer": "Sarcoidosis is a systemic granulomatous disease that affects numerous organs, commonly manifesting at the lungs and skin. Corticosteroids remain the first line of treatment.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28696638",
    "http://www.ncbi.nlm.nih.gov/pubmed/27817209",
    "http://www.ncbi.nlm.nih.gov/pubmed/26419478",
    "http://www.ncbi.nlm.nih.gov/pubmed/16536004",
    "http://www.ncbi.nlm.nih.gov/pubmed/10719453",
    "http://www.ncbi.nlm.nih.gov/pubmed/17081481",
    "http://www.ncbi.nlm.nih.gov/pubmed/27421131",
    "http://www.ncbi.nlm.nih.gov/pubmed/26204816",
    "http://www.ncbi.nlm.nih.gov/pubmed/10598414",
    "http://www.ncbi.nlm.nih.gov/pubmed/28056473",
    "http://www.ncbi.nlm.nih.gov/pubmed/29137908",
    "http://www.ncbi.nlm.nih.gov/pubmed/23884295",
    "http://www.ncbi.nlm.nih.gov/pubmed/23880702",
    "http://www.ncbi.nlm.nih.gov/pubmed/24753153",
    "http://www.ncbi.nlm.nih.gov/pubmed/28474323",
    "http://www.ncbi.nlm.nih.gov/pubmed/23538719"
  ],
  "snippets": [
    {
      "text": "Sarcoidosis represents a non-caseating, granulomatous disorder of unknown aetiology whose clinical manifestation is heterogeneous and frequently multisystemic. The portion of patients needing systemic treatment varies: though many patients may undergo spontaneous remission, organ-threatening courses demand systemic therapy. Corticosteroids are the first-line treatment option",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28056473",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " The prevalence of cardiac sarcoidosis has exponentially increased over the past decade, primarily due to increased awareness and diagnostic modalities for the disease entity. Despite an expanding patient cohort, the optimal management of cardiac sarcoidosis remains yet to be established with a significant lack of prospective trials to support current practice. Corticosteroids remain first-line treatment of this disorder,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28474323",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Prednisone is used as first-line therapy for pulmonary sarcoidosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29137908",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Corticosteroids are still the first-line treatment, but alternative therapy with anti-TNF agents, like pentoxifylline, thalidomide and anti-TNF monoclonal antibodies become more interesting, especially in refractory sarcoidosis.<br>",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16536004",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Corticosteroids are still the first-line treatment, but alternative therapy with anti-TNF agents, like pentoxifylline, thalidomide and anti-TNF monoclonal antibodies become more interesting, especially in refractory sarcoidosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16536004",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "While corticosteroids remain the first line of treatment, tumour necrosis factor alpha (TNF-\u03b1) inhibitors have been investigated as one potential steroid sparing treatment for sarcoidosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26419478",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Systemic corticosteroids are the first line treatment in sarcoidosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28696638",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Although glucocorticosteroids are considered the first-line treatment in sarcoidosis, refractory cases require alternatives, such as methotrexate (MTX).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23880702",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Corticosteroids remain the first-line therapy for sarcoidosis as many patients never require treatment or only necessitate a short treatment duration.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23884295",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Corticosteroids are still the first-line treatment, but alternative therapy with anti-TNF agents, like pentoxifylline, thalidomide and anti-TNF monoclonal antibodies become more interesting, especially in refractory sarcoidosis..",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16536004",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Glucocorticoid treatment is first-line therapy for hepatic sarcoidosis, improving symptoms and abnormal laboratory values but generally having no effect on progression of disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17081481",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Steroids remain the first-choice therapeutic in sarcoidosis; however, long-term use is associated with toxicity.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23538719",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Glucocorticoids are the first-line therapy for sarcoidosis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27817209",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Oral glucocorticoids are the standard first-line treatment for sarcoidosis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26204816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Corticosteroids are used as first-line treatment in organ-threatening sarcoidosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24753153",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Corticosteroids still remain first-line therapy in sarcoidosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27421131",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Generally, oral corticosteroids are considered the first-line treatment for symptomatic patients with pulmonary sarcoidosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10598414",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "https://meshb.nlm.nih.gov/record/ui?ui=D017565",
    "http://www.disease-ontology.org/api/metadata/DOID:11335",
    "http://www.disease-ontology.org/api/metadata/DOID:13406",
    "http://www.disease-ontology.org/api/metadata/DOID:13407",
    "https://meshb.nlm.nih.gov/record/ui?ui=D012507",
    "http://www.disease-ontology.org/api/metadata/DOID:13405",
    "http://www.disease-ontology.org/api/metadata/DOID:13402",
    "http://www.disease-ontology.org/api/metadata/DOID:13403"
  ],
  "exact_answer": "Corticosteroids"
}